Gild Bullish trend-line Play

Gilead Sciences , Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company's products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency virus (HIV) infection; and Vosevi, Vemlidy, Epclusa, Harvoni, and Viread products for treating liver diseases.

Entry $77.50 area
Target $2 trailing stoploss

I been trading this stock for over a year now and once it form it's base, it usually hold itself very well in it's pattern.
we could've easily scalped this stock multiple time this month for easy gain if you just buy the dip at the trend line with a tight stoploss.